Dopamine and Aβ-induced stress signaling and decrements in Ca 2+ buffering in primary neonatal hippocampal cells are antagonized by blueberry extract

Journal of Alzheimer's Disease

Volumn 11, Issue 4, 2007, Pages 433-446

  Joseph, J A ^a   Carey, A ^b   Brewer, G J ^c   Lau, F C ^a   Fisher, D R ^a  

^a TUFTS UNIVERSITY   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[25-35]; BLUEBERRY EXTRACT; DOPAMINE; PLANT EXTRACT; POTASSIUM CHLORIDE; UNCLASSIFIED DRUG; ANTIOXIDANT; CALCIUM; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MUSCARINIC RECEPTOR; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; BLUEBERRY; BRAIN NERVE CELL; CALCIUM SIGNALING; CELL PROTECTION; CONTROLLED STUDY; DEPOLARIZATION; DRUG EFFECT; DRUG EFFICACY; HIPPOCAMPUS; NERVE CELL CULTURE; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL LINE; CELL MEMBRANE POTENTIAL; FLUORESCENCE MICROSCOPY; HOMEOSTASIS; METABOLISM; NERVE CELL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; PHYTOTHERAPY; SIGNAL TRANSDUCTION;

AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; BLUEBERRY PLANT; CALCIUM; CELL LINE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOPAMINE; HIPPOCAMPUS; HOMEOSTASIS; MEMBRANE POTENTIALS; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEURONS; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; PROTEIN KINASE C; RATS; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION;

EID: 34447641797     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2007-11404     Document Type: Article

References (53)

1. Z. Yan and J. Feng, Alzheimer's disease: interactions between cholinergic functions and beta-amyloid, Curr Alzheimer Res 1(4) (2004), 241-248.
2. C.W. Xie, Calcium-regulated signaling pathways: role in amyloid beta-induced synaptic Dysfunction, Neuromolecular Med 6(1) (2004), 53-64.
3. L.M. Billings, S. Oddo, K.N. Green , J.L. McGaugh and F.M. Laferla, Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice, Neuron 45(5) (2005), 675-688.
4. T.C. Foster and A. Kumar, Calcium dysregulation in the aging brain, Neuroscientist 8(4) (2002), 297-301.
5. H. Hartmann, K. Velbinger, A. Eckert and W.E. Muller, Region-specific downregulation of free intracellular calcium in the aged rat brain, Neurobiol Aging 17(4) (1996), 557-563.
6. J.A. Joseph, B. Shukitt-Hale, N.A. Denisova, D. Bielinski, A. Martin, J.J. McEwen and P.C. Bickford, Reversals of age-related declines in neuronal signal transduction, cognitive and motor behavioral deficits with blueberry, spinach or strawberry dietary supplementation, J Neurosci 19 (1999), 8114-8121.
7. 2+ regulation and gene expression in normal brain aging, Trends Neurosci 10 (2004), 614-620.
8. G.J. Brewer, A. Lim, N.G Capps and J.R. Torricelli, Age-related calcium changes, oxyradical damage, caspase activation and nuclear condensation in hippocampal neurons in response to glutamate and beta-amyloid, Exp Gerontol 40(5) (2005), 426-437.
9. +-evoked dopamine release from superfused striatal slices: Reversals by PBN or Trolox, Free Radic Biol Med 20 (1996), 821-830.
10. P. De Sarno, S.A. Shestopal, T.D. King, A. Zmijewska, L. Song and R.S. Jope, Muscarinic receptor activation protects cells from apoptotic effects of DNA damage, oxidative stress and mitochondrial inhibition, J Biol Chem 278 (2003), 11086-11093.
11. J.A. Joseph, B. Shukitt-Hale and G. Casadesus, Reversing the deleterious effects of aging on neuronal communication and behavior: The beneficial properties of fruit polyphenolics, Amer J Clin Nutrition 81(suppl) (2005), 313S-3136S.
12. M.C. Polidori, Antioxidant micronutrients in the prevention of age-related diseases, J Postgrad Med 49(3) (2003), 229-235.
13. N.B. Chauhan, Multiplicity of garlic health effects and Alzheimer's disease, J Nutr Health Aging 9(6) (2005), 421-432.
14. I. Cantuti-Castelvetri, B. Shukitt-Hale and J.A. Joseph, Neurobehavioral aspects of antioxidants in aging, Int J Devl Neurosci 18 (2000), 367-381.
15. J.A. Joseph, G. Arendash, M. Gordon, D. Diamond, B. Shukitt-Hale and D. Morgan, Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model, Nutr Neurosci 6 (2003), 153-163.
16. J.A. Joseph and D.R. Fisher, Muscarinic receptor subtype determines vulnerability to amyloid beta in transfected COS-7 cells, J Alzheimers Dis 4 (2003), 1-12.
17. J.A. Joseph, D. Fisher and A. Carey, Fruit extracts antagonize Abeta- or DA-induced deficits in CA2+ flux in M1-transfected COS-7 cells, J Alzheimers Dis 6 (2004), 403-411.
18. S. Bastianetto and R Quirion, Natural extracts as possible protective agents of brain aging, Neurobiol Aging 23 (2002), 891-897.
19. E.D. Owuor and A.N. Kong, Antioxidants and oxidants regulated signal transduction pathways, Biochem Pharmacol 64 (2002), 765-770.
20. Y.C. Chen, Y.C. Liang, S.Y. Lin Shiau, C.T. Ho and J.K. Lin, Inhibition of TPA-induced protein kinase C and transcription activator protein-1 binding activities by theaflavin-3,3′ - digallate from black tea in NIH3T3 cells, J Agric Food Chem 47 (1999), 1416-1421.
21. M. Nardini, C. Scaccini, L. Packer and F. Virgili, In vitro inhibition of the activity of phosphorylase kinase, protein kinase C and protein kinase A by caffeic acid and a procyanidin-rich pin bark (Pinus marittima) extract, Bocmim Biophys Acta 1474 (2000), 219-225.
22. K. Iijima, M. Yoshizumi and Y. Ouchi, Effect of red wine polyphenols on vascular smooth muscle cell function - molecular mechanism of the French paradox, Mech Ageing Dev 123 (2002), 1033-1039.
23. J.A. Joseph, D.R. Fisher and D. Bielinski, Blueberry extract alters oxidative stress-mediated signaling in COS-7 cells transfected with selectively vulnerable muscarinic receptor subtypes, J Alzheimers Dis 9(1) (2006), 35-42.
24. J.A. Joseph, D.R. Fisher and J. Strain, Muscarinic receptor subtype determines vulnerability to oxidative stress in COS-7 cells, Free Radic Biol Med 32 (2002), 153-161.
25. 2+ indicators with greatly improved fluorescence properties, Journal of Biological Chemistry 260 (1985), 3440-3450.
26. L.M. He, L.Y. Chen, X.L. Lou, A. Qu, L.Z. Zhou and T. Xu, Evaluation of beta-amyloid peptide 25-35 on calcium homeostasis in cultured rat dorsal root ganglion neurons, Brain Res 7 (2002), 65-75.
27. G.E. Stutzmann, I. Smith, A. Caccamo, S. Oddo, F.M. Laferla and I. Parker, Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice, J Neurosci 10 (2006), 5180-5189.
28. C. O'Neill, R.F. Cowburn, W.L. Bonkale, T.G. Ohm, J. Fastbom, M. Carmody and M. Kelliher, Dysfunctional intracellular calcium homeostasis: a central cause of neurodegeneration in Alzheimer Disease, Biochem Soc Symp 67 (2001), 177-194.
29. R. Ho, D. Ortiz and T.B. Shea, Amyloid-beta promotes calcium flux and neurodegeneration via stimulation of L-voltage-sensitive calcium channels rather than NMDA channels in cultured neurons, J Alzheimers Dis 3 (2001), 479-483.
30. J. Kasparova, V. Lisa, S. Tucek and V. Dolezal, Chronic exposure of NG108-15 cells to amyloid beta peptide (A beta (1-42)) abolishes calcium influx via N-type calcium channels, Neurochem Res 26 (2001), 1079-1084.
31. D.D. Flynn, G. Ferrari-DiLeo, A.I. Levey and D.C. Mash, Differential alterations in muscarinic receptor subtypes in Alzheimer disease: implications for cholinergic based therapies, Life Sci 56 (1995), 869-876.
32. G. Ferrari-DiLeo, D.C. Mash and D.D. Flynn, Attenuation of muscarinic receptor-G-protein interaction in Alzheimer disease, Mol Chem Neuropathol 24 (1995), 69-91.
33. C.J. Ladner and J.M. Lee, Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer disease brain: differential sensitivity to agonists and divalent cations, Exp Neurol 158 (1999), 451-458.
34. J.J. Claus, E.A. Dubois, J. Booij, J. Habraken, J.C. de Munck, M. van Herk, B. Verbeeten Jr. and E.A. vaan Royen, Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography, Eur J Nucl Med 24 (1997), 602-608.
35. N.A. Muma, R. Mariyappa, K. Williams and J.M. Lee, Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters, Synapse 47 (2003), 58-65.
36. J.A. Joseph, B. Shukitt-Hale, N.A. Denisova, A. Martin, G. Perry and M.A. Smith, Copernicus revisited: amyloid beta in Alzheimer disease, Neurobiol Aging 22 (2001), 131-146.
37. W.F Chiou, Effect of Abeta exposure on the mRNA expression patterns of voltage-sensitive calcium channel alpha(1) subunits (alpha(1A)-alpha(1D)) in human SK-N-SH neuroblastoma, Neurochem Int (in press).
38. M.L. Michaelis, S. Ansar, Y. Chen, E.R. Reiff, K.I Seyb, R.H. Himes, K.L Audus and G.I. Georg, {beta}-Amyloid-induced neurodegeneration and protection by structurally diverse microtubule-stabilizing agents, J Pharmacol Exp Ther 312(2) (2005), 659-668.
39. A. Awasthi, Y. Matsunaga and T. Yamada, Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides, Exp Neurol 196(2) (2005), 282-289.
40. H.J. Heo and C.Y. Lee, Epicatechin and catechin in cocoa inhibit amyloid beta protein induced apoptosis, J Agric Food Chem 53(5) (2005), 1445-1448.
41. M.H. Li, J.H. Jang, B. Sun and Y.J. Surh, Protective effects of oligomers of grape seed polyphenols against beta-amyloid-induced oxidative cell death, Ann NY Acad Sci 1030 (2004), 317-329.
42. D.E. Frigo, B.N. Duong, L.I. Melnik, L.S. Schief, B.M. Collins-Burow, D.K. Pace, J.A. McLachlan and M.E. Burow, Flavonoid phytochemicals regulate activator protein-1 signal transduction pathways in endometrial and kidney stable cell lines, J Nutr 132(7) (2002), 1848-1853.
43. S. Martin, L. Favot, R. Matz, C. Lugnier and R. Andriantsitohaina. Delphinidin inhibits endothelial cell proliferation and cell cycle progression through a transient activation of ERK-1/-2, Biochem Pharmacol 65(4) (2003), 669-675.
44. C.S. Fahlman, P.E. Bickler, B. Sullivan and G.A. Gregory, Activation of the neuroprotective ERK signaling pathway by fructose-1-6-bisphosphate during hypoxia involves intracellular Ca2+ and phospholipase C, Brain Res 958 (2002), 43-51.
45. P.K. Dash, S.A. Mach and A.N. Moore, The role of extracellular signal-regulated kinase in cognitive and motor deficits following experimental traumatic brain injury, Neurosci 114 (2002), 755-767.
46. L. Colucci-D'Amato, C. Perrone-Capano and U. Di Porzio, Chronic activation of ERK and neurodegenerative diseases, Bioessays 25 (2003), 1085-1095.
47. K. Ayasolla, M. Khan, A.K. Singh and I. Singh, Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E, Free Radic Biol Med 37(3) 2004, 325-338.
48. D. Beitner-Johnson and D.E. Millhorn, Hypoxia induces phosphorylation of the cyclic AMP response element-binding protein by a novel signaling mechanism, J Biol Chem 273(31) (1998), 19834-19839.
49. E.P. Cummins and C.T. Taylor, Hypoxia-responsive transcription factors, Pflugers Arch 450(6) (2005), 363-371.
50. O.G. Rodriguez-Mora, C.J. Howe, M.M. Lahair, J.A. McCubrey and R.A. Franklin, Inhibition of CREB transcriptional activity in human T lymphocytes by oxidative stress, Free Radic Biol Med 38(12) (2005), 1653-1661.
51. P. Rockwell, J. Martinez, L. Papa and E. Gomes, Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium, Cell Signal 16(3) (2004), 343-353.
52. V. Gerzanich, S. Ivanova and J.M. Simard, Early pathophysiological changes in cerebral vessels predisposing to stroke, Clin Hemorheol Microcirc 29(3-4) (2003), 291-294.
53. D. Lin and D.J. Takemoto, Oxidative activation of protein kinase Cgamma through the C1 domain. Effects on gap junctions, J Biol Chem 280(14) (2005), 13682-13693.